| 2025 Kim Y., Doma V.,Çakır U, Magdalena Kuras M. Lazaro Hiram Betancourt PhD5, Pla I., Sanchez A., Sugihara Y.Appelqvist R.Oskolas H.Lee B.Guedes J.Monnerat G.Alves Carneiro G. R. Nogueira F. C. S., . Domont G.B., Malm J.Baldetorp B,Wieslander E.Németh I. B.,Szász A. M.,Hong R.Pawłowski K.Rezeli M.Kwon H. J.,Tímár J., Fenyö D.,Kárpáti S.,Marko-Varga G. and Gil J., Mitochondrial Proteome Landscape Unveils KeyInsights into Melanoma Severity and Treatment Strategies, Cancer (Wiley), 2025, In Press Olde B., Amisten S. Rezeli M. Grossi M, Bryl-Gorecka P., Håkansson A., Torngren K., Marko-Varga G., Erlinge D., The DNA repair factor ku80 binds and activates the adhesion receptor ELTD1/ADGRL4, Biophys. Res. Com., 2025, Vol 76, 1 June Oskolas H. , Nogueira F. C. N., Domont G. B., , Kun-Hsing Yu, Eugene R. Semenov,Peter Sorger, Erik Stenfelder, Les Corps, Lesley Schulz, Elisabet Wieslander, David Fenyö, Lajos Kemény Peter Hollo, Balazs Döme, Zsolt Megyesfalvi, Krzysztof Pawlowski, Toshihide Nishimura, HoJeong Kwon, Sergio Encarnacion-Guevara, A. Marcell Szasz, Zoltan Vereb, István Balázs Németh, Roger Appelqvist3, Johan Malm2 , Marko-Varga G., and Gil J., Comprehensive Biobanking Strategy with Clinical Impact at the European Cancer Moonshot Lund Center, “WHITE PAPER” J. Proteomics, 2025, 15:105442 Guedes J., ., Szadai L., Woldmar N.,Jánosi, A. J., Koroncziová K., Lengyel B. M.,Kelemen B. , Boltas E.,Gyulai R., Wieslander E., Pawlowski K., Horvatovich P.,Betancourt L., A. Marcell Szasz, Vereb Z., Horvath, P., Appelqvist R., Oskolás H., Malm J., Marko-Varga G., Németh B. I and Gil J., The Melanoma MEGA-Study: Harnessing AI-Driven Technological Advancements, J. Proteomics, 2024, under review Ngassie M.L.K., De Vries M., Borghuis T., Timens W., Sin D.D. D. Marko-Varga G Joub R., Prakash Y.S., Burgess J. K., Brandsma C.A., Age-associated Differences in the Human Lung Extracellular Matrix, Amer. J. Phys-Lung Cell. Mol. Phys., Fulöp A., Gil J., Horvath-Rozsas A., Solymosi D., Bogos K., Ferencz B., Berta J., Dome P., Marko-Varga G., Dome B., Kerpel-Fronius A., Megyesfalvi Z., “Machine learning- enhanced X-ray-based radiomics identifies post-COVID patients” Archivos de Bronconeumologia., Jan-2025 https://www.sciencedirect.com/science/article/pii/S0300289624004769?via%3Dihub Herrera Quiterio ., Abraham Valencia-González H., Griselda de la Cruz- López K., Fernández-Coto D., Gil J., Marko-Varga, G Morales-Gálvez J., Sánchez-Castellanos N., Rodríguez-Bautista R., Avilés-Salas A., Arrieta O., García-Carranca A., Encarnacion-Guevara S., TMEM160 promotes tumor growth in lung adenocarcinoma and cervical adenocarcinoma cell lines, Int. J. Mol. Sci., Genomics and Proteomics; ACCEPTED Bartha A., 2, Weltz B., Betancourt L. H., Gil J., Almeida N., Bianchini G., Szeitz B., Szadai L., Pla I., Kemény L. V., Jánosi A. J., Hong R., Rajeh A., Nogueira F., Doma V., Woldmar N., Guedes J., Újfaludi, Y Z., Kim Y., Szarvas T., Pahi Z., Pankotai T., Szasz A. M., Sanchez A., Baldetorp B, Tímár J., Németh I. B., Kárpáti S., Appelqvist R., Domont G., Pawlowski K., Wieslander E., Malm J., Fenyo D., Horvatovich P., Marko-Varga G, Győrffy B., “MEL-PLOT: a web-based platform for the discovery and validation of proteomic biomarker in melanoma”, 2025, J. Proteome Res., https://pubs.acs.org/toc/jprobs/0/0 Pla I., Szabolcs B. L., Péter P. N., Ujfaludi Z, Kim Y., Horvatovich P., Sanchez A.,Pawlowski K., Wieslander E., Guedes J., Pál D.M., Ascsillán A. A.,Betancourt L. H., Németh , I. B. Gil J., Pinto de Almeida N., Szeitz B., Szadai L., Doma V., Woldmar N., Bartha A., Pahi Z., 20, Pankotai T., Győrffy B., Szasz A, M., Domont G., Nogueira F., Kwon H. J., Appelqvist R., Kárpáti S., Fenyö D., Malm J. , Marko-Varga G., Kemény L. V., Protein biomarkers in the paraffine-archived human melanoma samples, J. Invest Derm., 2025, 145, 870–881 |
2024
| * Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts Szadai L., Bartha A., Pla Parada I., Lakatos A., Pál D., Lengyel A. S., Almeida N., Jánosi A., Nogueira F., Szeitz B., Doma V., Woldmar N., Guedes J., Újfaludi Z., Kim Y., Pahi Z., Pankotai T., Győrffy B., Szasz A. M., Betancourt L., Gil J., Appelqvist R., Németh I. B., Malm J., Fenyö D., Pawłowski K., Horvatovich P., Wieslander E., Kemény L. V., Domont G., Marko-Varga G., Sanchez A., Front. Oncol., 02 July 2024, Sec. Skin Cancer, Volume 14 – 2024 | https://doi.org/10.3389/fonc.2024.1428182 * Development and Validation of Time-to-Event Models to Predict Metastatic Recurrence of Localized Cutaneous Melanoma Wan G., Bonnie W. Leung, B. V., , DeSimone, M. S., Nguyen, N., Rajeh, R., Collier, M. R.,, Rashdan, H., Roster, K., Zhou, X., Moseley C., Nirmal, A. J.,, Pelletier, R. J.,, Maliga Z., Marko-Varga G., Nemeth I. B., Tsao H., Asgari M. M.,, Hurlbert M., Stagner, A. M., Lian, C. G., Yu K-H., Sorger, P. K., Liu, F., and Semenov Y.R., 2023, J. Amer. Acad. Derm., Volume 90, Issue 2, February 2024, Pages 288-298. https://doi.org/10.1016/j.jaad.2023.08.105 * Identifying Ferroptosis Inducers, HDAC, and RTK Inhibitor Sensitivity in Melanoma Subtypes through Unbiased Drug Target Prediction Indira Pla, Botond L. Szabolcs, Petra Nikolett Péter, Zsuzsanna Ujfaludi, Yonghyo Kim, Peter Horvatovich, Aniel Sanchez, Krzysztof Pawlowski, Elisabet Wieslander, Jéssica Guedes, Dorottya MP Pál, Anna A. Ascsillán, Lazaro Hiram Betancourt, István Balázs Németh, Jeovanis Gil, Natália Pinto de Almeida, Beáta Szeitz, Leticia Szadai, Viktória Doma, Nicole Woldmar, Áron Bartha, Zoltan Pahi, Tibor Pankotai, Balázs Győrffy, A. Marcell Szasz, Gilberto Domont, Fábio Nogueira, Ho Jeong Kwon, Roger Appelqvist, Sarolta Kárpáti, David Fenyö, Johan Malm, György Marko-Varga, Lajos V. Kemény: , bioRxiv 2024.02.08.579424. https://doi.org/10.1101/2024.02.08.579424 * Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanoma Pinto de Almeida N, Jánosi ÁJ, Hong R, Rajeh A, Nogueira F, Szadai L, Szeitz B, Pla Parada I, Doma V, Woldmar N, Guedes J, Újfaludi Z, Bartha A, Kim Y, Welinder C, Baldetorp B, Kemény LV, Pahi Z, Wan G, Nguyen N, Pankotai T, Győrffy B, Pawłowski K, Horvatovich P, Szasz AM, Sanchez A, Kuras M, Rodriguez Murillo J, Betancourt L, Domont GB, Semenov YR, Yu KH, Kwon HJ, Németh IB, Fenyő D, Wieslander E, Marko-Varga G, Gil J: Clin Transl Med 19 July 2024; 14(7):e1773. https://doi.org/10.1002/ctm2.1773 * Molecular signature of interferon treatment at the functional proteome level Vízkeleti, L, Papp O., Doma V., Gil. J. Markó-Varga G., Kovács S. A., Győrffy B., KárpátiS and Tímár J., Sci Report, 2024, In Press |
2023
- Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases
Woldmar N., , Schwendenwein A., Kuras M. , Szeitz B. , Boettiger K. , Tisza A., László V- , Reiniger L. , Bagó A. G., Szállási Z. Moldvay J., Szász A. M. Malm J. , Horvatovich P., Pizzatti L. , Domont G. B., Rényi-Vámos F., Hoetzenecker F. , Hoda M. A. , Marko-Varga G., Schelch K. , Megyesfalvi Z., Rezeli M., B. Döme B., ESMO Open, 2023, 8, (1), 1-13
Impact Factor: 4.43 - Unfolding the Secrets of Small Cell Lung Cancer Progression: Novel Approaches and Leveraging insights through Rapid Autopsies
Megyesfalvi Z., Heeke S., Drapkin B. J., Schwendenwein A., Kovacs A., Boettiger K., Horvath L., Ernhofer B., Fillinger J., Renyi-VamosF., Aigner C., Schelch K., Lang C., Marko-VargaG., Van Loo P., Hirsch F. R., Dome B., , Cancer Cell, 2023. 41, 9, 1535-1540.
Impact Factor: 38.585 - Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function
Mörtberg J., Salzinger B., Lundwall K. , Edfors R. , Jacobson S. H., Wallén H. N. , Jernberg T. , Baron T, Erlinge D., Andell P., James S., Eggers K.M. , Hjort M., Kahan T., Lundman P. , Tornvall P., Rezeli M. , Marko-Varga G., Lindahl B., and Spaak J., Int. J. Cardiol, 2023, 373, 64-71
Impact Factor: 4.164 - Histopathology-assisted proteogenomics provides foundations for stratification of melanoma metastases
Kuras M., Betancourt L. H., Hong, R., Szadai L., Rodriguez Murillo JHorvatovich P., Pla I.,Ericsson J., Szeit B., Deszzc B., Welinder C., Sugihara Y., Ekedahl H., Baldetorop B., Ingvar C., Lundgren L., Lindberg H., Oskolas H., Horvath Z., Rezeli M., Gil. J., Appelqvist R., Kemeny L. V., Malm J., Sanchez A., Szasz A. M., Pawlowski K., Wieslander E., Fenyö D. Nemeth I. B., and Marko-Varga G., BioRx, 2023. - Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry
Timar J., Honn K. V., Hendrix M. J. C., Marko-Varga G., Jalkanen S., Cancer and Metast. Rev., 2023, Feb, 08. https://doi.org/10.1007/s10555-023-10087-1
Impact Factor: 9.246 - Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer
Valko Z., Megyesfalvi Z., Schwendenwein A., Lang C., Paku S. , Barany N. , B., Ferencz , Horvat-Rozszas A., Kovacs I., Schlegl E., Pozonec V. , Boettiger K., Rezeli M., Marko-Varga G., Renyi-Vamos F., Alireza Hoda M., Klikovits T. , Hoetzenecker K. , Grusch M., Laszlo V, Döme B., and Schelch K., 2023, British J. Cancer, 2023, 187,
Impact Factor: 9.075 - Age-associated Differences in the Human Lung Extracellular Matrix
Ngassie, M. L. De Vries, T. Borghuis, W. Timens, Don D. Sin D. Nickle, P. Joubert, P. Horvatovich7, Marko-Varga G., J.J. Teske, J.M. Vonk, R. Gosens, Y.S. Prakash, J.K. Burgess, C.A. Brandsma, 2023, Am. J. Phys-Lung Cell Mol. Phys. 2023, 324, 5, p. L799-L814 doi: 10.1152/ajplung.00334.2022
Impact Factor: 6.011 - Regulation of human oocyte maturation in vivo during the final maturation of follicles
Cadenas, J., Poulsen, L. C., Nikiforov, D., Grøndahl, M. L., Kumar, A., Bahnu, K., Englund, A. L. M. Malm J. Marko-Varga G., Pla, I., Sanchez A., Pors, S. E. & Yding Andersen, C., 2023, Human Reproduction. 38, 4, p. 686-700.
Impact Factor: 6.353 - Improved Melatonin Dissolution Properties: A Way Forward for Treating Children with Sleep Disorders
Gil, Jeovanis; Malm, Johan and Marko-Varga, György, 2023. In Dissolution Technologies 30(2). p.662022
- Prediction of early-stage melanoma recurrence using clinical and histopathologic features.
Wan G., Nga Nguyen N., Feng Liu F., DeSimone M.S., Leung B. W., Rajeh A. ,Collier M. R., , Choi M. S. , Amadife M. , Tang K. , Zhang S. , Phillipps J. S. , Jairath R. , Alexander N. A. , Hua Y., Jiao M , Chen W., Ho1 D. , Stacey Duey1 , Németh I. B. , Marko-Varga G. , Gil Valdés J. , Liu D. ,. Boland G. M. , Gusev A. , Sorger P.L. , Yu K-H., and Semenov Y. R., “”, NPJ Prec. Oncol., 2022, 6, 1-16
Impact Factor: 10.092 - In-depth proteomic analysis reveals unique subtype-specific signatures in human small cell lung cancer.
Szeitz B, Megyesfalvi Z., Woldmar N., Valkó Z., Schwendenwein A. , Bárány N., Paku S. , László V., Bugyik E., Lang C. , Szász A. M. , Pizzatti L. , Hoda M. A., Hoetzenecker K. , Marko-Varga G. , Horvatovich P. , Döme B., Schelch K., Rezeli M.”, Clin. Transl. Sci , 2022, 12, (9), e1060
Impact Factor: 12.53 - Lipid metabolic reprogramming in operable pancreatic cancer and tumor margin
Pirhonen J., Szkalisity A., Hagström J., Kim Y., Migh E., Kovacs M., Hölttä M., Peränen J., Seppänen H., Haglund C., Gil J., Rezeli M., Malm J., Horvath P., Marko-Varga G., Puolakkainen P., Ikonen E., , Cancer Res, 2022, Nov 2;82(21):3932-3949
Impact Factor: 14.099 - Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer: an international multicenter study
Megyesfalvi Z., Barany N., Lantos A., Valko Z., Pipek O., Lang C., Schwendenwein A., Oberndorfer F., Paku S., Ferencz B., Fillinger J., Lohinai Z., Moldvay J., Galffy G., Rezeli M., Rivard C., Hirsch F. R., Brcic L., Popper H., Kern I., Kovacevic M., Skarda J., Mitták M., Marko-Varga G, Bogos K, Renyi-Vamos F., Hoda A. M., Klikovits T., Hoetzenecker K., Schelch K., Laszlo V., Dome B., J. Pathology, 2022, Aug;257(5):674-686
Impact Factor: 7.99 - Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization
Governa, Talbot, Gonçalves de Oliveira K, Cerezo Magaña, Bång Rudenstam, Johansson, Månsson, Forsberg Nilsson K, Marko Varga G, Enríquez Pérez J, Darabi A, Malmström J Bengzon J, Welinder C, Belting M., PNAS , 2022, 119 (9) e2114456119
Impact Factor: 11.205 - The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition.
Hegedüs L., Livingstone E. Bánkfalvi A., Viehof J., Enyedi A., Bilecz A., Győrffy B., Baranyi M., Tőkés A-M, Gil J., Marko‐varga, G., Griewank K. G., Zimmer L., Váraljai R., Sucker A., Dirk Schadendorf Z. A., Aigner C. and Hegedüs B., 2022, In: Int. J. Mol. Sci., 2022, 23, 6, 3324
2021
- Matrix assisted laser desorption ionization – mass spectrometry imaging of erlotinib reveals a new cause of drug resistance in a non-small-cell lung cancer mouse xenograft model
Kim T. Y., Lee B., Kim Y., Sugihara Y., Rezeli M., Szasz A. M., Dome B., Marko‐varga, G., Kwon H.J., 2021 Jul., In: Translational Medicine. 11, 7, e481. - Proteogenomics Reveals how Metastatic Melanoma Modulates the Immune System to Allow Immune Evasion
Gil, J., Szeitz B., Kim, Y., Doma V., Çakır U., Almeida, N., Hagemeijer Y., Guryev V., Johansson J. G., SharmaY., Pla I., Horvath Z., de Siqueira Guedes J., Monnerat G., Reis Alves Carneiro G., Nogueira F., Lee B., Henriett Oskolas, Sugihara, Y., Kuras M., Roger Appelqvist, Wieslander E., Domont G. B., Baldetorp, B., Hong R., Timar J., Fenyö D., Betancourt L. H., Jakobsson J., Malm, J., Sanchez, A., A. Marcell Szasz, Horvatovich P., Rezeli, M., Karpati S., and Marko‐varga, G., 2021, In: Bio-RXiv, 2021, - An observational study on the molecular profiling of primary melanomas reveals a progression dependence on mitochondrial activation
Gil, J., Rezeli, M., Lutz, E. G., Kim, Y., Sugihara, Y., Malm, J., Semenov, Y. R., Yu, K. H., Nguyen, N., Wan, G., Kemény, L. V., Kárpáti, S., Németh, I.B. & Marko‐varga, G., 2021 Dec., In: Cancers. 13 , 23, 6066. - Apelin promotes blood and lymph vessel formation and the growth of melanoma lung metastasis
Berta, J., Török, S., Tárnoki-Zách, J., Drozdovszky, O., Tóvári, J., Paku, S., Kovács, I., Czirók, A., Masri, B., Megyesfalvi, Z., Oskolás, H., Malm, J., Ingvar, C., Markó-Varga, G., Döme, B. & László, V., 2021, In: Scientific Reports. 11, 1, 5798. - Deep proteomic analysis on biobanked paraffine-archived melanoma with prognostic/predictive biomarker read-out
Szadai, L., Velasquez, E., Szeitz, B., de Almeida, N. P., Domont, G., Betancourt, L. H., Gil, J., Marko-Varga, M., Oskolas, H., Jánosi, Á. J., Boyano-Adánez, M. D.C., Kemény, L., Baldetorp, B., Malm, J., Horvatovich, P., Szász, A.M., Németh, I.B. & Marko-Varga, G., 2021 Dec., In: Cancers. 13, 23, 6105. - Development of Novel VEGFR2 Inhibitors Originating from Natural Product Analogues with Antiangiogenic Impact
Cho, S.M., Kim, Y., Jung, Y., Ko, M., Marko-Varga, G. & Kwon, H. J., 2021 Nov., In: Journal of Medicinal Chemistry. 64, 21, p. 15858-15867 10 p. - Mapping the melanoma plasma proteome (MPP) using single-shot proteomics interfaced with the WiMT database
Almeida, N., Rodriguez, J., Parada, I. P., Perez-Riverol, Y., Woldmar, N., Kim, Y., Oskolas, H., Betancourt, L., Valdés, J. G., Sahlin, K.B., Pizzatti, L., Szasz, A.M., Kárpáti, S., Appelqvist, R., Malm, J., Domont, G.B., Nogueira, F.C. S., Marko-Varga, G. & Sanchez, A., 2021 Dec. 1, In: Cancers. 13, 24, 6224. - Organ specific copy number variations in visceral metastases of human melanoma
Papp, O., Doma, V., Gil, J., Markó-Varga, G., Kárpáti, S., Tímár, J. & Vízkeleti, L., 2021 Dec., In: Cancers. 13, 23, 5984. - Pipelines and Systems for Threshold-Avoiding Quantification of LC-MS/MS Data
Sánchez Brotons, A., Eriksson, J. O., Kwiatkowski, M., Wolters, J.C., Kema, I. P., Barcaru, A., Kuipers, F., Bakker, S. J. L., Bischoff, R., Suits, F. & Horvatovich, P., 2021 Aug. 17, In: Analytical Chemistry. 93, 32, p. 11215-11224 10 p. - Proteomic Workflows for High-Quality Quantitative Proteome and Post-Translational Modification Analysis of Clinically Relevant Samples from Formalin-Fixed Paraffin-Embedded Archives
Kuras, M., Woldmar, N., Kim, Y., Hefner, M., Malm, J., Moldvay, J., Dome, B., Fillinger, J., Pizzatti, L., Gil, J., Marko-Varga, G. & Rezeli, M., 2021, In: Journal of Proteome Research. 20, 1, pp. 1027–1039 - The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome
Betancourt, L. H., Gil, J., Sanchez, A., Kuras, M., Velasquez, E., Kim, Y., Sugihara, Y., Parada, I. P., Appelqvist, R., Wieslander, E., Welinder, C., de Almeida, N. P., Woldmar, N., Marko-Varga, M., Eriksson, J., Baldetorp, B., Ingvar, C., Olsson, H., Lundgren, L., Lindberg, H.& 15 others, , 2021, In: Clinical and Translational Medicine. 11, 7, pp. 1-25 e451. - The human melanoma proteome atlas-Defining the molecular pathology
Betancourt, L. H., Gil, J., Kim, Y., Doma, V., Çakır, U., Sanchez, A., Murillo, J. R., Kuras, M., Parada, I. P., Sugihara, Y., Appelqvist, R., Wieslander, E., Welinder, C., Velasquez, E., de Almeida, N. P., Woldmar, N. , Marko-Varga, M., Pawłowski, K., Eriksson, J., Szeitz, B. & 37 others, , 2021, In: Clinical and Translational Medicine. 11, 7, pp. 1-20 e473.
2020
- MSIWarp: A General Approach to Mass Alignment in Mass Spectrometry Imaging
Eriksson, J. O., Sánchez Brotons, A., Rezeli, M., Suits, F., Markó-Varga, G. & Horvatovich, P., 2020, In: Analytical Chemistry. 92, 24, pp. 16138–16148 - Novel functional proteins coded by the human genome discovered in metastases of melanoma patients
Sanchez, A., Kuras, M., Murillo, J. R., Pla, I., Pawlowski, K., Szasz, A.M., Gil, J., Nogueira, F.C. S., Perez-Riverol, Y., Eriksson, J., Appelqvist, R., Miliotis, T., Kim, Y., Baldetorp, B., Ingvar, C., Olsson, H., Lundgren, L., Ekedahl, H., Horvatovich, P., Sugihara, Y.& 8 others, , 2020 June, In: Cell Biology and Toxicology. 36, 3, p. 261-272 12 p. - Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
Kim, Y., Gil, J., Pla, I., Sanchez, A., Betancourt, L. H., Lee, B., Appelqvist, R., Ingvar, C., Lundgren, L., Olsson, H., Baldetorp, B., Kwon, H. J., Oskolás, H., Rezeli, M., Doma, V., Kárpáti, S. , Szasz, A.M., Németh, I.B., Malm, J. & Marko-Varga, G., 2020 Mar 24, In: Cancers. 12, 3, 767. - A biobanking turning-point in the use of formalin-fixed, paraffin tumor blocks to unveil kinase signaling in melanoma
A biobanking turning-point in the use of formalin-fixed, paraffin tumor blocks to unveil kinase signaling in melanoma
Velasquez, E., Szadai, L., Zhou, Q., Kim, Y., Pla, I., Sanchez, A., Appelqvist, R., Oskolas, H., Marko-Varga, M., Lee, B., Kwon, H. J., Malm, J., Szász, A.M., Gil, J., Betancourt, L. H., Németh, I.B. & Marko-Varga, G., 2021, In: Clinical and Translational Medicine. 11, 8, p. 1-6 e466. - Matrix-assisted laser desorption ionization – mass spectrometry imaging of erlotinib reveals a limited tumor tissue distribution in a non-small-cell lung cancer mouse xenograft model
Kim, T. Y., Lee, B., Kim, Y., Sugihara, Y., Rezeli, M., Szasz, A.M., Dome, B., Marko-Varga, G. & Kwon, H. J., 2021, In: Clinical and Translational Medicine. 11, 7, e481. - Targeting the hydrophilic regions of recombinant proteins by MS via in-solution buffer-free trypsin digestion
Betancourt, L. H., Espinosa, L. A., Ramos, Y., Bequet-Romero, M., Rodríguez, E. N., Sánchez, A., Marko-Varga, G., González, L. J. & Besada, V., 2020 Jun 1, In: European Journal of Mass Spectrometry. 26, 3, p. 230-237 8 p.
2019
- Assessing Automated Sample Preparation Technologies for High-Throughput Proteomics of Frozen Well Characterized Tissues from Swedish Biobanks
Kuras, M., Betancourt, L. H., Rezeli, M., Rodriguez, J., Szasz, M., Zhou, Q., Miliotis, T., Andersson, R. & Marko-Varga, G., 2019, In: Journal of Proteome Research. 18, 1, pp. 548–556 9 p. - Challenging the heterogeneity of disease presentation in malignant melanoma—impact on patient treatment
Marcell Szasz, A., Malm, J., Rezeli, M., Sugihara, Y., Betancourt, L. H., Rivas, D., Gyorffy, B. & Marko-Varga, G., 2019, In: Cell Biology and Toxicology. 35, 1, p. 1-14 - Clinical protein science in translational medicine targeting malignant melanoma
Gil, J., Betancourt, L. H., Pla, I., Sanchez, A., Appelqvist, R., Miliotis, T., Kuras, M., Oskolas, H., Kim, Y., Horvath, Z., Eriksson, J., Berge, E., Burestedt, E., Jönsson, G., Baldetorp, B., Ingvar, C., Olsson, H., Lundgren, L., Horvatovich, P., Murillo, J. R. & 18 others, , 2019, In: Cell Biology and Toxicology. 35, 4, p. 293-332 - Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
Betancourt, L. H., Pawłowski, K., Eriksson, J., Szasz, A.M., Mitra, S., Pla, I., Welinder, C., Ekedahl, H., Broberg, P., Appelqvist, R., Yakovleva, M., Sugihara, Y., Miharada, K., Ingvar, C., Lundgren, L., Baldetorp, B., Olsson, H., Rezeli, M., Wieslander, E., Horvatovich, P. & 3 others, , 2019 March 26, In: Scientific Reports. 9, 1, 5154. - The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
Betancourt, L. H., Szasz, A. M., Kuras, M., Murillo, J. R., Sugihara, Y., Pla, I., Horvath, Z., Pawłowski, K., Rezeli, M., Miharada, K., Gil, J., Eriksson, J., Appelqvist, R., Miliotis, T., Baldetorp, B., Ingvar, C., Olsson, H., Lundgren, L., Horvatovich, P., Welinder, C. & 8 andra, , 2019, I: Cancers. 11, 12, 1981.
2018
- Automated phosphopeptide enrichment from minute quantities of frozen malignant melanoma tissue
Murillo, J. R., Kuras, M., Rezeli, M., Milliotis, T., Betancourt, L. & Marko-Varga, G., 2018 dec. 10, I: PLoS ONE. 13, 12, e0208562. - Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
Sugihara, Y., Rivas, D., Malm, J., Szasz, M., Kwon, H., Baldetorp, B., Olsson, H., Ingvar, C., Rezeli, M., Fehniger, T. E. & Marko-Varga, G., 2018 aug. 6, I: Clinical and Translational Medicine. 7, s. 1-9 22. - Quantitative Assessment of Urea In-Solution Lys-C/Trypsin Digestions Reveals Superior Performance at Room Temperature over Traditional Proteolysis at 37 °C.
Betancourt, L., Sanchez, A., Pla Parada, I., Kuras, M., Zhou, Q., Andersson, R. & Marko-Varga, G., 2018 maj 29, I: Journal of Proteome Research. 17, 7, s. 2556−2561 6 s.
- Prediction of early-stage melanoma recurrence using clinical and histopathologic features.